Zhanjun Jia Selected Research

UK-383,367

12/2019

BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhanjun Jia Research Topics

Disease

35	Inflammation (Inflammations) 07/2022 - 02/2010
18	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2014
18	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2011
13	Fibrosis (Cirrhosis) 07/2022 - 12/2013
10	Chronic Renal Insufficiency 01/2022 - 09/2014
10	Ureteral Obstruction 11/2021 - 01/2014
10	Kidney Diseases (Kidney Disease) 01/2020 - 01/2014
9	Proteinuria 01/2021 - 01/2010
8	Neoplasms (Cancer) 01/2022 - 12/2008
8	Hypertension (High Blood Pressure) 01/2021 - 11/2006
7	Albuminuria 06/2018 - 12/2013
6	Anemia 01/2022 - 01/2012
6	Ischemia 12/2021 - 10/2008
5	Hypoxia (Hypoxemia) 01/2022 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
4	Body Weight (Weight, Body) 02/2021 - 07/2010
4	Obesity 02/2021 - 01/2018
4	Wounds and Injuries (Trauma) 01/2018 - 12/2014
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014 - 01/2013
3	Sclerosis 01/2021 - 12/2013
3	Atherosclerosis 01/2020 - 01/2016
3	Polyuria 01/2020 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2013
2	Sepsis (Septicemia) 01/2021 - 01/2018
2	Peritoneal Fibrosis 01/2021 - 02/2010
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 01/2017
2	Bites and Stings (Sting) 01/2021 - 01/2021
2	Alkalosis 01/2020 - 10/2018
2	Reperfusion Injury 01/2020 - 10/2008
2	Hyperaldosteronism (Conn Syndrome) 01/2020 - 10/2018
2	Bartter Syndrome (Syndrome, Bartter) 01/2020 - 10/2018
2	Vascular System Injuries 05/2019 - 01/2017
2	Necrosis 01/2019 - 01/2015
2	Vascular Diseases (Vascular Disease) 11/2018 - 01/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 01/2012

Drug/Important Bio-Agent (IBA)

14	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2015
13	Dinoprostone (PGE2)FDA Link 07/2022 - 11/2008
9	RotenoneIBA 12/2019 - 01/2014
8	SaltsIBA 01/2019 - 11/2006
7	InflammasomesIBA 07/2021 - 09/2014
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
7	SodiumIBA 01/2018 - 11/2006
6	LipidsIBA 07/2022 - 01/2015
6	ProstaglandinsIBA 01/2022 - 11/2008
6	Prostaglandin-E SynthasesIBA 01/2021 - 12/2009
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
5	manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA 01/2022 - 04/2015
5	roxadustatIBA 01/2022 - 01/2018
5	AlbuminsIBA 01/2019 - 04/2015
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2016 - 01/2010
4	Adenosine Triphosphate (ATP)IBA 01/2022 - 06/2014
4	EnzymesIBA 01/2022 - 02/2010
4	AldosteroneIBA 07/2021 - 01/2016
4	celastrolIBA 02/2021 - 01/2018
4	Angiotensin IIIBA 01/2021 - 11/2008
4	Mitochondrial DNA (mtDNA)IBA 01/2021 - 06/2014
4	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2019 - 01/2018
4	Prostaglandins EIBA 11/2018 - 12/2009
4	CXA-10IBA 12/2013 - 10/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	superoxide dismutase 2IBA 01/2021 - 01/2018
3	Caspase 3 (Caspase-3)IBA 01/2021 - 07/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2013
3	CollagenIBA 12/2019 - 05/2018
3	Fibronectins (Fibronectin)IBA 12/2019 - 12/2008
3	NPHS2 proteinIBA 01/2017 - 06/2014
3	nephrinIBA 01/2017 - 06/2014
3	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2015 - 02/2010
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022 - 01/2020
2	Prolyl-Hydroxylase InhibitorsIBA 01/2022 - 01/2018
2	Pregnane X ReceptorIBA 12/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 12/2019
2	AntioxidantsIBA 01/2021 - 11/2008
2	artenimol (dihydroartemisinin)IBA 01/2020 - 11/2018
2	CilomilastIBA 01/2020 - 01/2020
2	LithiumIBA 01/2020 - 12/2009
2	Chloride Channels (Chloride Channel)IBA 01/2020 - 10/2018
2	Interleukin-6 (Interleukin 6)IBA 04/2019 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 02/2010
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 01/2018 - 01/2017
2	Aquaporins (Water Channels)IBA 01/2018 - 10/2016
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017 - 01/2011
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 01/2017 - 01/2016
2	CytokinesIBA 04/2015 - 02/2010
2	Acetates (Acetic Acid Esters)FDA Link 01/2015 - 07/2011
2	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2015 - 07/2011
2	Thiobarbituric Acid Reactive SubstancesIBA 12/2013 - 01/2010
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2013 - 07/2011
2	EndotoxinsIBA 01/2011 - 03/2010
2	tempolIBA 02/2010 - 11/2008
1	Methionine (L-Methionine)FDA Link 07/2022
1	heme receptorIBA 07/2022
1	Acyl Coenzyme A (Acyl CoA)IBA 07/2022

Therapy/Procedure

12	Therapeutics 07/2022 - 01/2016
4	Nephrectomy 01/2021 - 01/2012
2	Ligation 01/2021 - 01/2018
2	Peritoneal Dialysis 01/2021 - 02/2010